Sino Biological Announces Successful Closing of 4.98 Billion RMB Public Offering and Listing on the Shenzhen ChiNext Stock Exchange

Sino Biological’s successful listing on the capital market is an important milestone in its strategic plan for growth. While justifying its current business model and portfolio, this offering also conveys a new starting point for the company’s future growth…

Click here to view the original article.